Header Logo

Connection

Naoko Takebe to Topotecan

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Topotecan.
Naoko Takebe
Connection Strength
0.044
Topotecan
  1. A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):481-5.
    View in: PubMed
    Score: 0.023
  2. A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies. Cancer Chemother Pharmacol. 2010 Nov; 66(6):1079-85.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.